Annual Drug Patent Expirations for ENJUVIA
Enjuvia is a drug marketed by Aspen and is included in one NDA. There are two patents protecting this drug.
This drug has seventeen patent family members in nine countries.
The generic ingredient in ENJUVIA is estrogens, conjugated synthetic b. Additional details are available on the estrogens, conjugated synthetic b profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
